| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/17/1992 | EP0490434A1 Labelled, modified oligonucleotides |
| 06/17/1992 | EP0490383A2 Peptides of the HIV-gag protein, their preparation and use |
| 06/17/1992 | EP0489968A1 Synthetic antigens for the detection of antibodies to hepatitis C virus |
| 06/17/1992 | EP0489837A1 Inhibition of lymphocyte adherence to vascular endothelium utilizing a novel extracellular matrix receptor-ligand interaction |
| 06/17/1992 | EP0215131B1 E87ag antigen of pseudomonas aeruginosa, monoclonal antibody against it, and hybridoma |
| 06/17/1992 | EP0185680B1 Steroidal liposomes |
| 06/17/1992 | DE4040043A1 New acid-stable and infectious human rhinovirus mutant - prepd. by incubating wild type virus at varying pH, useful for treating rhinoviral infection |
| 06/16/1992 | US5122471 Cloned genes coding for avian coccidiosis antigens which induce a cell-mediated immune response |
| 06/16/1992 | US5122448 Mixing sample with polypeptide, determining presence of immunoreaction |
| 06/16/1992 | US5122373 Immunoglobulin-g-containing fraction |
| 06/16/1992 | US5122368 Anthracycline conjugates having a novel linker and methods for their production |
| 06/16/1992 | CA1303534C Human anti-rh(d) monoclonal antibodies |
| 06/16/1992 | CA1303533C Human anti-rh(d) monoclonal antibodies |
| 06/16/1992 | CA1303531C Choriocarcinoma monoclonal antibodies and antibody panels |
| 06/16/1992 | CA1303525C Rotavirus reassortant vaccine |
| 06/16/1992 | CA1303524C Drug-monoclonal antibody conjugates |
| 06/16/1992 | CA1303500C Feline infectious peritonitis vaccine |
| 06/16/1992 | CA1303499C Method for immunization against and treatment of infection by ectoparasites and endoparasites |
| 06/15/1992 | WO1992010506A1 Human retrovirus receptor and dna coding therefor |
| 06/15/1992 | CA2097705A1 Human retrovirus receptor and dna coding therefor |
| 06/11/1992 | WO1992010582A1 Monokine mig induced by ifn-gamma |
| 06/11/1992 | WO1992009693A1 Human parainfluenza virus type 4a fusion protein and gene which codes for the same |
| 06/11/1992 | WO1992009684A1 Recombinant avirulent salmonella antifertility vaccines |
| 06/11/1992 | WO1992009632A1 Fragments of the env protein of the feline immunodeficiency virus, antibodies and their applications in diagnosis |
| 06/11/1992 | WO1992009617A1 Cell stress transcriptional factors |
| 06/11/1992 | WO1992009563A1 Improved matrix metalloprotease inhibitors |
| 06/11/1992 | WO1992009305A1 Anti cd-4 antibodies blocking hiv-induced syncytia |
| 06/11/1992 | WO1992009293A1 Inhibition of cell adhesion protein-carbohydrate interactions |
| 06/11/1992 | WO1992009282A1 Treatment for tissue ulceration |
| 06/11/1992 | WO1992009200A1 Novel polypeptides for promoting cell attachment |
| 06/11/1992 | DE4139840A1 Compsns. contg. antigen from cell-associated protein of H. pylorus - useful for sensitive selective detection of antibodies with less false positives and negatives |
| 06/11/1992 | CA2097617A1 Inhibition of cell adhesion protein-carbohydrate interactions |
| 06/11/1992 | CA2096225A1 Matrix metalloprotease inhibitors |
| 06/11/1992 | CA2057292A1 Labelled, modified oligonucleotides |
| 06/10/1992 | EP0489153A1 Vaccine compositions containing liposomes |
| 06/10/1992 | EP0489138A1 Vaccine composition for treating human chlamydial diseases. |
| 06/10/1992 | EP0489113A1 The use of thioredoxin in the treatment of malignantly transformed cells in animals and man |
| 06/10/1992 | CA2098101A1 A vaccine against cholesterol to prevent hypercholesterolemia and atherosclerosis |
| 06/09/1992 | US5120834 Fibrin-specific monoclonal antibody |
| 06/09/1992 | US5120642 Medical diagnosis |
| 06/09/1992 | US5120639 Neutralizing herpes simplex virus DNA polymerase using an antibody obtained from a specified decapeptide and measuring amount of bound antibody |
| 06/09/1992 | US5120525 Radiolabeled antibody cytotoxic therapy of cancer |
| 06/09/1992 | CA1303292C Anhydrous enhanced coupling |
| 06/09/1992 | CA1302919C Histamine derivatives, immunogen conjugates and antibodies raised thereto |
| 06/09/1992 | CA1302884C Pasteurization of immunoglobulin solutions |
| 06/09/1992 | CA1302883C Method of preparing toxoid |
| 06/09/1992 | CA1302882C Vaccines and immunoglobulin g-containing preparations active against pseudomonas aeruginosa |
| 06/05/1992 | CA2031455A1 Method for producing hybridoma antibodies and their use |
| 06/04/1992 | WO1992009613A1 Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diphtheria toxin |
| 06/04/1992 | DE4038189A1 Epididymis-specific DNA sequences |
| 06/04/1992 | CA2097416A1 Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diphtheria toxin |
| 06/03/1992 | EP0488718A2 Immunostimulant agent containing interleukin-2 and 5'-deoxy-5-fluorouridine |
| 06/03/1992 | EP0488061A2 The MAC-1 binding site of ICAM-1 |
| 06/03/1992 | EP0487909A2 Novel muramyldipeptide derivatives and influenza vaccine comprising the derivatives |
| 06/03/1992 | EP0487718A1 NUCLEIC ACID PROBES with negatively charged haptens which are attached to the probe via a hydrazine binding moiety |
| 06/03/1992 | EP0487632A1 Stabilized vaccine compositions |
| 06/03/1992 | EP0487629A1 Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs |
| 06/03/1992 | EP0487627A1 Wound healing preparations containing heparanase |
| 06/03/1992 | EP0487610A1 Prohormone cleavage site blocking antibody |
| 06/03/1992 | EP0487587A1 Recombinant retroviruses delivering vector constructs to target cells |
| 06/03/1992 | EP0371049B1 Method for the diagnosis of infections with detection of lipopolysaccharide antigens |
| 06/03/1992 | EP0202260B1 Improved antigenic preparation |
| 06/03/1992 | EP0174990B1 Immunofixation electrophoresis process |
| 06/02/1992 | US5118795 Viral inactivation by freeze drying; heating; reconstituting concentrate |
| 06/02/1992 | US5118602 Feline T-lymphotropic lentivirus assay |
| 06/02/1992 | US5118502 Administering nonpathogenic virus to cause immunization in the animal; respiratory system disorder |
| 06/02/1992 | US5118501 Polypeptidic composition useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of antimerozoite antibodies |
| 06/02/1992 | US5118500 Side effect reduction when administering a xanthine derivative |
| 06/02/1992 | CA1302268C Pharmaceutical compositions containing diltiazem and an enzyme inhibitor |
| 05/31/1992 | WO1992010760A1 Methods for the diagnosis of chronic lower back and cervical pain |
| 05/31/1992 | CA2097426A1 Method for the diagnosis of chronic lower back and cervical pain |
| 05/30/1992 | CA2056555A1 Immunostimulant agent containing interleukin-2 and 5'-deoxy-5-fluorouridine |
| 05/29/1992 | WO1992008983A1 Hiv marker/aids vaccine |
| 05/29/1992 | WO1992008789A1 Measles virus recombinant poxvirus vaccine |
| 05/29/1992 | WO1992008785A1 Diagnosis and treatment of multiple sclerosis |
| 05/29/1992 | WO1992008734A1 Hepatitis c virus asialoglycoproteins |
| 05/29/1992 | WO1992008732A1 Synthetic peptide producing antibodies to ldh-c¿4? |
| 05/29/1992 | WO1992008491A1 Conjugates of anti-idiotype antibodies and carriers and their use in epitope-directed immunization |
| 05/29/1992 | WO1992008487A1 Recombinant feline coronavirus s proteins |
| 05/29/1992 | WO1992008486A1 Avirulent microbes and uses therefor: salmonella typhi |
| 05/29/1992 | WO1992008484A1 Mycobacterium vaccae in the treatment of uveitis |
| 05/29/1992 | WO1992008480A1 A β-TYPE TRANSFORMING GROWTH FACTOR |
| 05/29/1992 | WO1992008474A2 Treatment of lung diseases |
| 05/29/1992 | CA2096441A1 Heterodimer of b-type transforming growth factors 2 and 3 |
| 05/29/1992 | CA2056143A1 The mac-1 binding site of icam-1 |
| 05/27/1992 | EP0487289A2 Cyclosporin immunoassay |
| 05/27/1992 | EP0486809A2 Use of suramin against TNF-related diseases |
| 05/27/1992 | EP0486652A1 Multivalent antigen-binding proteins |
| 05/27/1992 | EP0486622A1 Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
| 05/27/1992 | EP0486572A1 Improvements in granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| 05/27/1992 | EP0486562A1 Mutant pseudorabies virus, and vaccines containing the same |
| 05/27/1992 | EP0486507A1 Anthelmintic non-living vaccine |
| 05/27/1992 | EP0486495A1 Expression system for actinomycetes and related organisms |
| 05/26/1992 | US5116964 Hybrid immunoglobulins |
| 05/26/1992 | US5116952 Protein active in humoral hypercalcemia of malignancy-pthrp |
| 05/26/1992 | US5116946 Synthetic, immunologically active peptides useful for the preparation of antimalarial vaccines |
| 05/26/1992 | US5116814 Process for the remission of symptoms associated with AIDS |
| 05/26/1992 | US5116755 Asexual blood stage antigens of plasmodium falciparum which encode a rhoptry protein |
| 05/26/1992 | US5116731 Process for the detection of an allergy or an anti-allergic substance |
| 05/26/1992 | US5116726 Methods for removal of detergents from analytes |